|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0030685,
umls-concept:C0031928,
umls-concept:C0205314,
umls-concept:C0227843,
umls-concept:C0391871,
umls-concept:C0679622,
umls-concept:C0680255,
umls-concept:C0694756,
umls-concept:C1274040,
umls-concept:C1280500,
umls-concept:C1283071,
umls-concept:C1510932,
umls-concept:C1963578
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2007-8-20
|
|
pubmed:abstractText |
Continuous administration of progesterone antagonists (PAs) results in endometrial suppression and amenorrhoea in several model systems. We compared the effects of intrauterine release of a highly specific PA, ZK230211, to those of a progestin using the levonorgestrel-releasing intrauterine system (LNG-IUS).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0268-1161
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2515-22
|
|
pubmed:meshHeading |
pubmed-meshheading:17636280-Adult,
pubmed-meshheading:17636280-Biological Markers,
pubmed-meshheading:17636280-Cell Proliferation,
pubmed-meshheading:17636280-Drug Delivery Systems,
pubmed-meshheading:17636280-Endometrium,
pubmed-meshheading:17636280-Endothelium,
pubmed-meshheading:17636280-Estrenes,
pubmed-meshheading:17636280-Female,
pubmed-meshheading:17636280-Humans,
pubmed-meshheading:17636280-Immunohistochemistry,
pubmed-meshheading:17636280-Insulin-Like Growth Factor Binding Protein 1,
pubmed-meshheading:17636280-Ki-67 Antigen,
pubmed-meshheading:17636280-Menorrhagia,
pubmed-meshheading:17636280-Middle Aged,
pubmed-meshheading:17636280-Progesterone,
pubmed-meshheading:17636280-Receptors, Progesterone
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Intrauterine release of progesterone antagonist ZK230211 is feasible and results in novel endometrial effects: a pilot study.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynaecology, University of Helsinki, PO Box 140, SF-00029 HUS, Helsinki, Finland. oskari.heikinheimo@helsinki.fi
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
